1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: H-22706, NCT00390182
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CTCT 06-11, NCT00493883
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-099, NCT00539643
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-256, IST000508, NCT00813293
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: INST OX-05-024, NCT00832637
|
|
6.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: CELSION-1040610101, 104-06-101-01, NCT00441376
|
|
7.
|
Phase: Phase I Type: Treatment Status: Active Age: 45 and under Sponsor: Other Protocol IDs: 2004-0079, NCT00502892
|
|
8.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NYU 05-409, NCT00821652
|
|
9.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UWCC-6697, UWCC-6697, IR-6697, NCT00844168
|
|
10.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2003-0962, NCT00415675
|
|
11.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Cell Saver 704.03, NCT00708513
|
|
12.
|
Phase: No phase specified Type: Tissue collection/Repository, Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: HCI #18450, NCT00708877
|
|
13.
|
Phase: No phase specified Type: Treatment Status: Active Age: 21 to 85 Sponsor: Other Protocol IDs: 08-117, NCT00774501
|
|
14.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: PTI-LC-2007-01, R44-CA119502, NCT00782886
|
|
15.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 02-0836, NCT00878215
|